42.38 USD
+0.97 (+2.34%)
42.38 USD
0 (0%)
Overall ATRC gets a fundamental rating of 4 out of 10. We evaluated ATRC against 187 industry peers in the Health Care Equipment & Supplies industry. While ATRC has a great health rating, there are worries on its profitability. ATRC is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ATRC had negative earnings in the past year.
In the past year ATRC had a positive cash flow from operations.
In the past 5 years ATRC reported 4 times negative net income.
In multiple years ATRC reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of ATRC (-4.60%) is better than 67.38% of its industry peers.
ATRC's Return On Equity of -6.13% is fine compared to the rest of the industry. ATRC outperforms 69.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROIC | N/A |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ATRC (74.87%) is better than 85.56% of its industry peers.
ATRC's Gross Margin has been stable in the last couple of years.
ATRC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
2. Health
2.1 Basic Checks
ATRC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ATRC has been increased compared to 1 year ago.
The number of shares outstanding for ATRC has been increased compared to 5 years ago.
ATRC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 7.96 indicates that ATRC is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.96, ATRC belongs to the top of the industry, outperforming 87.17% of the companies in the same industry.
The Debt to FCF ratio of ATRC is 4.19, which is a neutral value as it means it would take ATRC, 4.19 years of fcf income to pay off all of its debts.
ATRC has a Debt to FCF ratio of 4.19. This is amongst the best in the industry. ATRC outperforms 80.75% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that ATRC is not too dependend on debt financing.
ATRC has a better Debt to Equity ratio (0.14) than 61.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Altman-Z | 7.96 |
ROIC/WACCN/A
WACC8.76%
2.3 Liquidity
A Current Ratio of 3.87 indicates that ATRC has no problem at all paying its short term obligations.
ATRC's Current ratio of 3.87 is fine compared to the rest of the industry. ATRC outperforms 66.84% of its industry peers.
ATRC has a Quick Ratio of 2.85. This indicates that ATRC is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.85, ATRC is doing good in the industry, outperforming 63.10% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 |
3. Growth
3.1 Past
ATRC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.88%, which is quite impressive.
Looking at the last year, ATRC shows a quite strong growth in Revenue. The Revenue has grown by 15.80% in the last year.
ATRC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.05% yearly.
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
3.2 Future
Based on estimates for the next years, ATRC will show a very strong growth in Earnings Per Share. The EPS will grow by 23.01% on average per year.
Based on estimates for the next years, ATRC will show a quite strong growth in Revenue. The Revenue will grow by 13.24% on average per year.
EPS Next Y45.54%
EPS Next 2Y32.85%
EPS Next 3Y31.56%
EPS Next 5Y23.01%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ATRC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ATRC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, ATRC is valued a bit cheaper than 68.98% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 129.6 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as ATRC's earnings are expected to grow with 31.56% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.85%
EPS Next 3Y31.56%
5. Dividend
5.1 Amount
ATRC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
42.38
+0.97 (+2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners99.91%
Inst Owner Change-2.45%
Ins Owners3.38%
Ins Owner Change-1.04%
Market Cap2.11B
Revenue(TTM)518.30M
Net Income(TTM)-29.20M
Analysts85.33
Price Target52.7 (24.35%)
Short Float %5.32%
Short Ratio5.27
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)89.89%
Min EPS beat(2)88.31%
Max EPS beat(2)91.46%
EPS beat(4)4
Avg EPS beat(4)71.41%
Min EPS beat(4)40.06%
Max EPS beat(4)91.46%
EPS beat(8)7
Avg EPS beat(8)36.37%
EPS beat(12)11
Avg EPS beat(12)39.56%
EPS beat(16)11
Avg EPS beat(16)28.77%
Revenue beat(2)2
Avg Revenue beat(2)1.41%
Min Revenue beat(2)0.29%
Max Revenue beat(2)2.54%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-1.4%
Max Revenue beat(4)2.54%
Revenue beat(8)4
Avg Revenue beat(8)0.17%
Revenue beat(12)6
Avg Revenue beat(12)0.47%
Revenue beat(16)9
Avg Revenue beat(16)0.72%
PT rev (1m)1.31%
PT rev (3m)1.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-11.06%
EPS NY rev (1m)8.56%
EPS NY rev (3m)15.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.5%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 4.07 | ||
| P/FCF | 129.6 | ||
| P/OCF | 49.08 | ||
| P/B | 4.42 | ||
| P/tB | 11 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.25
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.33
FCFY0.77%
OCF(TTM)0.86
OCFY2.04%
SpS10.42
BVpS9.58
TBVpS3.85
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.6% | ||
| ROE | -6.13% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 74.87% | ||
| FCFM | 3.14% |
ROA(3y)-6.75%
ROA(5y)-3.76%
ROE(3y)-8.8%
ROE(5y)-5.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y0.24%
F-Score7
Asset Turnover0.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 4.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 133.13% | ||
| Cap/Sales | 5.15% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.87 | ||
| Quick Ratio | 2.85 | ||
| Altman-Z | 7.96 |
F-Score7
WACC8.76%
ROIC/WACCN/A
Cap/Depr(3y)184.3%
Cap/Depr(5y)140.27%
Cap/Sales(3y)6.89%
Cap/Sales(5y)5.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)69.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.12%
EPS Next Y45.54%
EPS Next 2Y32.85%
EPS Next 3Y31.56%
EPS Next 5Y23.01%
Revenue 1Y (TTM)15.8%
Revenue growth 3Y19.26%
Revenue growth 5Y15.05%
Sales Q2Q%15.84%
Revenue Next Year15.08%
Revenue Next 2Y13.68%
Revenue Next 3Y13.55%
Revenue Next 5Y13.24%
EBIT growth 1Y21.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.64%
EBIT Next 3Y64.51%
EBIT Next 5Y43.19%
FCF growth 1Y137.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8487.4%
OCF growth 3YN/A
OCF growth 5YN/A
ATRICURE INC / ATRC FAQ
What is the fundamental rating for ATRC stock?
ChartMill assigns a fundamental rating of 4 / 10 to ATRC.
What is the valuation status of ATRICURE INC (ATRC) stock?
ChartMill assigns a valuation rating of 2 / 10 to ATRICURE INC (ATRC). This can be considered as Overvalued.
What is the profitability of ATRC stock?
ATRICURE INC (ATRC) has a profitability rating of 3 / 10.
What is the earnings growth outlook for ATRICURE INC?
The Earnings per Share (EPS) of ATRICURE INC (ATRC) is expected to grow by 45.54% in the next year.